HEMATOLOGY

Gestational Vascular Complications

Jun 21, 2016 by in HEMATOLOGY Comments Off on Gestational Vascular Complications

Gestational Vascular Complications Benjamiun Brenner Anat Aharon Jean-Christophe Gris PLACENTAL HEMOSTASIS IN NORMAL PREGNANCY AND GESTATIONAL VASCULAR COMPLICATIONS The placenta is a highly vascularized organ receiving blood supply from fetal…

read more

Heparin-Induced Thrombocytopenia

Jun 21, 2016 by in HEMATOLOGY Comments Off on Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia Theodore E. Warkentin Andreas Greinacher Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction caused by heparin-dependent, platelet-activating immunoglobulin (Ig) G antibodies that recognize complexes of platelet factor…

read more

Overview of Special Clinical Groups

Jun 21, 2016 by in HEMATOLOGY Comments Off on Overview of Special Clinical Groups

Overview of Special Clinical Groups Victor J. Marder Joel S. Bennett The majority of this textbook is devoted to basic aspects of hemostasis and thrombosis and specific hemostatic and thrombotic…

read more

Mechanical Devices and Embolectomy

Jun 21, 2016 by in HEMATOLOGY Comments Off on Mechanical Devices and Embolectomy

Mechanical Devices and Embolectomy HervÉ Decousus Patrick Mismetti Nicolas Meneveau VENA CAVA FILTERS AND VENOUS THROMBOEMBOLISM Interruption of the vena cava by filter insertion was initially suggested by Armand Trousseau…

read more

Foundations of Thrombolytic Therapy

Jun 21, 2016 by in HEMATOLOGY Comments Off on Foundations of Thrombolytic Therapy

Foundations of Thrombolytic Therapy Victor J. Marder Daphne B. Stewart Thrombolytic therapy represents a conjoint approach to vascular reperfusion, based primarily on the use of fibrinolytic agents delivered systemically or…

read more

Antiplatelet Therapy

Jun 21, 2016 by in HEMATOLOGY Comments Off on Antiplatelet Therapy

Antiplatelet Therapy Carlo Patrono As reviewed in other chapters, platelet activation and aggregation play a key role in atherothrombosis.1 Antiplatelet drugs target enzymes or receptors involved in the platelet synthesis…

read more

New Antithrombotic Drugs

Jun 21, 2016 by in HEMATOLOGY Comments Off on New Antithrombotic Drugs

New Antithrombotic Drugs Jeffrey I. Weitz Peter L. Gross Currently available antithrombotic drugs include (a) antiplatelet agents, which inhibit platelet activation or aggregation, (b) anticoagulants, which attenuate fibrin formation, and…

read more

Coumarin-Induced Skin Necrosis and Venous Limb Gangrene

Jun 21, 2016 by in HEMATOLOGY Comments Off on Coumarin-Induced Skin Necrosis and Venous Limb Gangrene

Coumarin-Induced Skin Necrosis and Venous Limb Gangrene Theodore E. Warkentin Thrombotic events that result from coumarin administration are incongruous but well-documented complications of anticoagulant therapy. The key role of coumarin…

read more
Get Clinical Tree app for offline access